Stewart W F, Lipton R B, Whyte J, Dowson A, Kolodner K, Liberman J N, Sawyer J
Innovative Medical Research, Towson, MD, USA.
Neurology. 1999 Sep 22;53(5):988-94. doi: 10.1212/wnl.53.5.988.
The Migraine Disability Assessment (MIDAS) instrument is a five-item questionnaire developed to measure headache-related disability and improve doctor-patient communication about the functional consequences of migraine.
To examine the test-retest reliability and internal consistency of the five items and of the overall MIDAS score in population-based samples of migraine sufferers in two countries and to compare consistency across countries.
Using a clinically validated telephone interview, population-based samples of migraine-headache sufferers were identified in the United States (Baltimore, MD) and the United Kingdom (Merton and Sutton, Surrey). Eligible individuals completed the MIDAS questionnaire on two occasions an average of 3 weeks apart. The MIDAS score is derived from five questions about missed time from work and household work (one question each about missed days and days with at least 50% reduced productivity) and missed days of nonwork activities.
A total of 97 migraine-headache sufferers from the United States and 100 from the United Kingdom completed the MIDAS questionnaire twice. Mean and median item values and overall MIDAS scores were similar between the United States and the United Kingdom. Test-retest Spearman correlations of individual items ranged from 0.46 to 0.78. No significant differences in item-specific correlations were observed between the United States and United Kingdom. The test-retest Pearson correlation of the MIDAS score (i.e., sum of lost days and reduced-effectiveness days in each domain) was 0.80 in the United States and 0.83 in the United Kingdom. The Cronbach alpha, a measure of internal consistency, was 0.76 in the United States and 0.73 in the United Kingdom.
This is the first international population-based study to assess the reliability of a disability-related illness severity score for migraine. The reliability and internal consistency of the Migraine Disability Assessment score are similar to that of a previous questionnaire (Headache Impact Questionnaire). However, the Migraine Disability Assessment score requires fewer questions, is easier to score, and provides intuitively meaningful information on lost days of activity in three domains.
偏头痛残疾评估(MIDAS)工具是一份包含五个条目的问卷,旨在测量与头痛相关的残疾情况,并改善医患之间关于偏头痛功能后果的沟通。
在两个国家基于人群的偏头痛患者样本中,检验这五个条目以及MIDAS总分的重测信度和内部一致性,并比较两国之间的一致性。
通过经过临床验证的电话访谈,在美国(马里兰州巴尔的摩)和英国(萨里郡默顿和萨顿)确定基于人群的偏头痛患者样本。符合条件的个体平均间隔3周分两次完成MIDAS问卷。MIDAS分数源自关于工作和家务时间缺失(各有一个关于缺勤天数和生产力至少降低50%的天数的问题)以及非工作活动缺勤天数的五个问题。
来自美国的97名偏头痛患者和来自英国的100名偏头痛患者完成了两次MIDAS问卷。美国和英国之间的平均和中位数条目值以及MIDAS总分相似。各个条目的重测斯皮尔曼相关性在0.46至0.78之间。在美国和英国之间未观察到特定条目相关性的显著差异。MIDAS分数(即每个领域中损失天数和效率降低天数的总和)的重测皮尔逊相关性在美国为0.80,在英国为0.83。内部一致性指标克朗巴哈α系数在美国为0.76,在英国为0.73。
这是第一项基于国际人群的研究,旨在评估偏头痛相关疾病严重程度评分的可靠性。偏头痛残疾评估分数的可靠性和内部一致性与先前的一份问卷(头痛影响问卷)相似。然而,偏头痛残疾评估分数所需问题更少,评分更容易,并且在三个领域中提供了关于活动损失天数的直观有意义的信息。